No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Loungers Agrees to Improved $433 Mln Fortress Takeover
Express News | Mustang Bio Announces Reverse Stock Split
Roth MKM Maintains Fortress Biotech(FBIO.US) With Buy Rating, Raises Target Price to $15
Fortress Biotech (FBIO) Gets a Buy From Roth MKM
Express News | Fortress Biotech Inc - FDA Sets Pdufa Target Action Date for Cutx-101 on June 30, 2025
Express News | Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for Cutx-101 (Copper Histidinate) Product Candidate for Treatment of Menkes Disease